一种双作用的脂质体-配方协同对抗一种功能增益的p53突变体
bioRxiv : the preprint server for biology
|October 1, 2025
概括
一种针对p53R273H突变的新型脂质体封装可以提高多克索鲁比在癌细胞中的疗效. 这种配方为克服这种常见的p53突变的瘤中抗药性提供了一个有希望的策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物运输 药物运输 药物运输
背景情况:
- 功能增益的p53突变,如R273H,驱动癌症的进展和耐药性.
- 突变的p53R273H蛋白与积极协活性剂4 (PC4) 相互作用,这对其致癌功能至关重要.
- 现有的疗法往往对携带p53R273H突变的瘤无效.
研究的目的:
- 开发和评估一种用于p53R273H突变癌症的新型治疗配方.
- 为了研究PC4向囊在阴阳性脂质体 (PC-SA) 中封装的的潜力,以提高抗癌药物疗效.
主要方法:
- 合成NLS-p53 ((380-386)) ,并将其封装到PC-SA脂质体中.
- 使用MTT测定,共聚焦显微镜,流细胞计,qRT-PCR和西式斑点测试来评估生物效应.
- 在p53R273H突变癌细胞系中对多克索鲁比辛增强化学敏感性的评估.
主要成果:
- 这种体封装的质显著增强了多克索鲁比诱导的癌细胞死亡.
- 使用封装的预处理比单独使用自由或脂质体更有效.
- 该配方在克服与p53R273H突变相关的耐药性方面表现出更好的疗效.
结论:
- 脂质组封装的NLS-p53(380-386) 是一种治疗p53R273H突变癌症的有希望的策略.
- 这种配方改善了抗癌疗法的输送和有效性.
- 进一步开发可能会导致针对耐药瘤的新型干预措施.
更多相关视频
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
1.7K
14:57Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
10.0K
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
